Real-time enrollment status for this neurofibromatosis type 1 clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 12:46 AM UTC
| NCT Number | NCT06541847 |
| Recruiting Status | Recruiting |
| Condition | Neurofibromatosis Type 1 |
| Phase | PHASE2 |
| Target Enrollment | 25 participants |
| Active Locations | 14 sites in the US |
| Sponsor | Healx Limited |
| Last Updated on CT.gov | July 29, 2026 (Jul 29, 2026) |
As of October 16, 2026: Clinical trial NCT06541847 is currently recruiting participants. This phase2 study for neurofibromatosis type 1 is actively seeking new participants at 14 locations across the United States. The study is sponsored by Healx Limited. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06541847 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06541847 was last updated Jul 29, 2026 (July 29, 2026). HelloStudys verifies this status automatically.